Lithium Australia looking to expand Australian lithium asset portfolio


Published 30-JAN-2017 14:57 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Lithium Australia (ASX:LIT) announced on Monday that it has applied for prospective tenements with pegmatite occurrences on Kangaroo Island, which is part of South Australia and lies approximately 100 kilometres south-west of Adelaide.

Best known as a high profile tourist destination and emerging wine region, Lithium Australia noted that there is also evidence on the island of pegmatite intrusives into the Tapanappa formation of the Kanmantoo Group.

In terms of geological make up, the group’s Managing Director Adrian Griffin said, “The pegmatite is predominantly feldspar-quartz-muscovite with varying amounts of topaz tourmaline varieties elbaite, rubellite and indicolite, graphite, citrine and apatite.

Providing some degree of assurance in terms of mineral presence is a geological survey conducted by the South Australian government which identified lepidolite in the area. However, there is no record of lithium exploration being conducted.

Successful entry into South Australia would expand and diversify asset base

Griffin commented on the strategic benefits of this development saying, “Our broadened nationwide search is designed to de-risks the company’s lithium exploration portfolio by providing exposure to multiple lithium opportunities across multiple state jurisdictions”.

Griffin said that the area identified on Kangaroo Island aligns with the group’s strategy of targeting potential deposits that are in the right geological environment, have past identification of the lithium minerals sweet and have historic pegmatite mining.

Lithium Australia’s share price has performed strongly in January having increased more than 50% with strong momentum occurring mid-month after the company announced that it had produced battery grade lithium carbonate.

Of course it should be noted that historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free